Heart Test Laboratories Stock Analysis
Heart Test's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Heart Test's financial risk is the risk to Heart Test stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Heart Test's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Heart Test is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Heart Test to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Heart Test is said to be less leveraged. If creditors hold a majority of Heart Test's assets, the Company is said to be highly leveraged.
Heart Test Laboratories is overvalued with Real Value of 0.0576 and Hype Value of 0.0605. The main objective of Heart Test stock analysis is to determine its intrinsic value, which is an estimate of what Heart Test Laboratories is worth, separate from its market price. There are two main types of Heart Test's stock analysis: fundamental analysis and technical analysis.
The Heart Test stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Heart Test is usually not traded on Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday. Heart Stock trading window is adjusted to America/New York timezone.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Heart Stock Analysis Notes
The company recorded a loss per share of 1.09. Heart Test Laboratories had not issued any dividends in recent years. The entity had 1:100 split on the 17th of May 2024. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. To learn more about Heart Test Laboratories call Andrew Simpson at 682 237 7781 or check out https://heartsciences.com.Heart Test Laboratories Investment Alerts
| Heart Test is not yet fully synchronised with the market data | |
| Heart Test is way too risky over 90 days horizon | |
| Heart Test has some characteristics of a very speculative penny stock | |
| Heart Test appears to be risky and price may revert if volatility continues | |
| Heart Test has high likelihood to experience some financial distress in the next 2 years | |
| Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the revenue of 4.35 K. Net Loss for the year was (8.77 M) with profit before overhead, payroll, taxes, and interest of 5.02 K. | |
| Heart Test Laboratories has accumulated about 723.48 K in cash with (7.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Heart Test has a frail financial position based on the latest SEC disclosures |
Technical Drivers
As of the 5th of January, Heart Test retains the risk adjusted performance of 0.1097, and Market Risk Adjusted Performance of (1.26). Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories standard deviation, as well as the relationship between the value at risk and kurtosis to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 0.0451 per share. As Heart Test Laboratories appears to be a penny stock we also urge to confirm its total risk alpha numbers.Heart Test Laboratories Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Simple Moving Average indicator is calculated by adding the closing price of Heart Test for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Heart Test Laboratories short-term fluctuations and highlight longer-term trends or cycles.
Heart Test Laboratories Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heart Test insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heart Test's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heart Test insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Danielle Watson over a week ago Acquisition by Danielle Watson of 15000 shares of Heart Test subject to Rule 16b-3 | ||
Andrew Simpson over a month ago Acquisition by Andrew Simpson of 70000 shares of Heart Test at 0.001 subject to Rule 16b-3 | ||
Wells David R. over three months ago Acquisition by Wells David R. of 25000 shares of Heart Test at 4.37 subject to Rule 16b-3 | ||
Danielle Watson over three months ago Acquisition by Danielle Watson of 9000 shares of Heart Test at 3.33 subject to Rule 16b-3 | ||
Mark Hilz over three months ago Disposition of 4416 shares by Mark Hilz of Heart Test at 3.5374 subject to Rule 16b-3 | ||
Bent Bruce over three months ago Acquisition by Bent Bruce of 6000 shares of Heart Test at 3.33 subject to Rule 16b-3 | ||
Danielle Watson over three months ago Acquisition by Danielle Watson of 25000 shares of Heart Test at 4.37 subject to Rule 16b-3 |
Heart Test Outstanding Bonds
Heart Test issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Heart Test Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Heart bonds can be classified according to their maturity, which is the date when Heart Test Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| PEAK 525 15 DEC 32 Corp BondUS42250PAE34 | View | |
| PEAK 2125 01 DEC 28 Corp BondUS42250PAD50 | View | |
| PEAK 135 01 FEB 27 Corp BondUS42250PAC77 | View |
Heart Test Predictive Daily Indicators
Heart Test intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heart Test stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.36 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.64 | |||
| Day Median Price | 0.0577 | |||
| Day Typical Price | 0.0535 | |||
| Market Facilitation Index | 0.0251 | |||
| Price Action Indicator | (0.03) | |||
| Period Momentum Indicator | (0.03) | |||
| Relative Strength Index | 35.03 |
Heart Test Forecast Models
Heart Test's time-series forecasting models are one of many Heart Test's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heart Test's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Heart Test Bond Ratings
Heart Test Laboratories financial ratings play a critical role in determining how much Heart Test have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Heart Test's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (4.02) | Unlikely Manipulator | View |
Heart Test Laboratories Debt to Cash Allocation
Many companies such as Heart Test, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Heart Test Laboratories has accumulated 2.99 M in total debt. Heart Test Laboratories has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Heart Test's use of debt, we should always consider it together with its cash and equity.Heart Test Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Heart Test's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Heart Test, which in turn will lower the firm's financial flexibility.Heart Test Corporate Bonds Issued
About Heart Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Heart Test prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heart shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heart Test. By using and applying Heart Stock analysis, traders can create a robust methodology for identifying Heart entry and exit points for their positions.
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Heart Test to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.